
Latest news, updates, and announcements from Iambic.

Takeda and Iambic Therapeutics have entered a $1.7 billion partnership to accelerate drug discovery for oncology and immunology. This collaboration utilizes AI models that have already demonstrated th...

Iambic's new $100M funding validates AI's transition from mere prediction to primary discovery in drug development. Their AI-designed cancer drug, IAM1363, is now advancing through Phase 1/1b clinical...